BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Welti J, Loges S, Dimmeler S, Carmeliet P. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest. 2013;123:3190-3200. [PMID: 23908119 DOI: 10.1172/jci70212] [Cited by in Crossref: 392] [Cited by in F6Publishing: 387] [Article Influence: 43.6] [Reference Citation Analysis]
Number Citing Articles
1 Cao W, Zhang N, He X, Xing Y, Yang N. Long non-coding RNAs in retinal neovascularization: current research and future directions. Graefes Arch Clin Exp Ophthalmol 2022. [PMID: 36171459 DOI: 10.1007/s00417-022-05843-y] [Reference Citation Analysis]
2 Chen G, Levin R, Landau S, Kaduri M, Adir O, Ianovici I, Krinsky N, Doppelt-Flikshtain O, Shklover J, Shainsky-Roitman J, Levenberg S, Schroeder A. Implanted synthetic cells trigger tissue angiogenesis through de novo production of recombinant growth factors. Proc Natl Acad Sci U S A 2022;119:e2207525119. [PMID: 36095208 DOI: 10.1073/pnas.2207525119] [Reference Citation Analysis]
3 Wang C, Li C, Hao R, Ali Sheikh MS. miR-559 Inhibits Proliferation, Autophagy, and Angiogenesis of Hepatocellular Carcinoma Cells by Targeting PARD3. Mediators of Inflammation 2022;2022:1-9. [DOI: 10.1155/2022/3121492] [Reference Citation Analysis]
4 Zhou Q, Xu Y, Shen L, Yang X, Wang L. Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma. Front Oncol 2022;12:852365. [DOI: 10.3389/fonc.2022.852365] [Reference Citation Analysis]
5 Liu T, Liu Q, Wang Y, Yang R, Tian F. Cuproptosis scoring model predicts overall survival and assists in immunotherapeutic decision making in pancreatic carcinoma. Front Genet 2022;13:938488. [DOI: 10.3389/fgene.2022.938488] [Reference Citation Analysis]
6 Wei S, Gu X, Zhang W. Development and validation of a novel fibroblast scoring model for lung adenocarcinoma. Front Oncol 2022;12:905212. [DOI: 10.3389/fonc.2022.905212] [Reference Citation Analysis]
7 Gu X, Zheng S, Zhang H, Sun X, Zhou Q. The cross-talk of cancer-associated fibroblasts assist in prognosis and immunotherapy in patients with breast carcinoma. Cancer Gene Ther 2022. [PMID: 35948763 DOI: 10.1038/s41417-022-00514-w] [Reference Citation Analysis]
8 Yang J, Chen H, Wang Y, Chen J. Development and validation of a robust necroptosis related classifier for colon adenocarcinoma. Front Genet 2022;13:965799. [DOI: 10.3389/fgene.2022.965799] [Reference Citation Analysis]
9 Cui F, Xu Z, Hu J, Lv Y. Spindle pole body component 25 and platelet-derived growth factor mediate crosstalk between tumor-associated macrophages and prostate cancer cells. Front Immunol 2022;13:907636. [DOI: 10.3389/fimmu.2022.907636] [Reference Citation Analysis]
10 Gielata M, Karpińska K, Gwiazdowska A, Boryń Ł, Kobielak A. Catulin reporter marks a heterogeneous population of invasive breast cancer cells with some demonstrating plasticity and participating in vascular mimicry. Sci Rep 2022;12:12673. [PMID: 35879327 DOI: 10.1038/s41598-022-16802-2] [Reference Citation Analysis]
11 Que H, Fu Q, Lan T, Tian X, Wei X. Tumor-associated neutrophils and neutrophil-targeted cancer therapies. Biochim Biophys Acta Rev Cancer 2022;:188762. [PMID: 35853517 DOI: 10.1016/j.bbcan.2022.188762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xu H, Lafage-Proust MH, Bouazza L, Geraci S, Clezardin P, Roche B, Peyrin F, Langer M. Impact of Anti-Angiogenic Treatment on Bone Vascularization in a Murine Model of Breast Cancer Bone Metastasis Using Synchrotron Radiation Micro-CT. Cancers (Basel) 2022;14:3443. [PMID: 35884504 DOI: 10.3390/cancers14143443] [Reference Citation Analysis]
13 Li S, Pritchard DM, Yu L. Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis. Cancers 2022;14:3263. [DOI: 10.3390/cancers14133263] [Reference Citation Analysis]
14 Cetin A, Biltekin B, Ozevren H. Antitumor activity of irinotecan with ellagic acid in C6 glioma cells. Rev Assoc Med Bras (1992) 2022;68:939-44. [PMID: 35946772 DOI: 10.1590/1806-9282.20220130] [Reference Citation Analysis]
15 Ren T, Jia H, Wu Q, Zhang Y, Ma Q, Yao D, Gao X, Xie D, Xu Z, Zhao Q, Zhang Y. Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab. Front Oncol 2022;12:829059. [DOI: 10.3389/fonc.2022.829059] [Reference Citation Analysis]
16 Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, Chen ZS, Ye W, Zhang D. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects. Drug Resist Updat 2022;64:100849. [PMID: 35842983 DOI: 10.1016/j.drup.2022.100849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Schiffmann LM, Bruns CJ, Schmidt T. Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy. Front Oncol 2022;12:897927. [PMID: 35664794 DOI: 10.3389/fonc.2022.897927] [Reference Citation Analysis]
18 Targhazeh N, Reiter RJ, Rahimi M, Qujeq D, Yousefi T, Shahavi MH, Mir SM. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy. Biochimie 2022:S0300-9084(22)00129-8. [PMID: 35618158 DOI: 10.1016/j.biochi.2022.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhou J, Hu Y, Zhu W, Nie C, Zhao W, Faje AT, Labelle KE, Swearingen B, Lee H, Hedley-whyte ET, Zhang X, Jones PS, Miller KK, Klibanski A, Zhou Y, Soberman RJ. Sprouting Angiogenesis in Human Pituitary Adenomas. Front Oncol 2022;12:875219. [DOI: 10.3389/fonc.2022.875219] [Reference Citation Analysis]
20 Yamada Y, Zhong Y, Miki S, Taura A, Rabbitts TH. The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis. Sci Rep 2022;12:7226. [PMID: 35508511 DOI: 10.1038/s41598-022-11297-3] [Reference Citation Analysis]
21 Feng X, Sun M, Wang X, Yin C, Wang M, Wang W, Yuan Z. A CuS-Based Nanoplatform Catalyzing NO Generation for Tumor Vessel Improvement and Efficient Chemotherapy. ACS Appl Nano Mater 2022;5:6901-10. [DOI: 10.1021/acsanm.2c00906] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Andrea AE, Chiron A, Mallah S, Bessoles S, Sarrabayrouse G, Hacein-Bey-Abina S. Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. Front Immunol 2022;13:830292. [PMID: 35211124 DOI: 10.3389/fimmu.2022.830292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Masood F, Bhattaram R, Rosenblatt MI, Kazlauskas A, Chang J, Azar DT. Lymphatic Vessel Regression and Its Therapeutic Applications: Learning From Principles of Blood Vessel Regression. Front Physiol 2022;13:846936. [DOI: 10.3389/fphys.2022.846936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kwak E, Pan CC, Ramonett A, Kumar S, Cruz-flores P, Ahmed T, Ortiz HR, Lochhead JJ, Ellis NA, Mouneimne G, Georgieva TG, Lee YS, Vanderah TW, Largent-milnes T, Mohler PJ, Hund TJ, Langlais PR, Mythreye K, Lee NY. βIV-spectrin as a stalk cell-intrinsic regulator of VEGF signaling. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-28933-1] [Reference Citation Analysis]
25 Wu ZL, Zhang WY, Zhong JC, Huang XJ, Xu W, Chen MF, Weng SQ, Zhang DM, Che CT, Ye WC, Wang Y. Angiogenesis-Inhibitory Piperidine Alkaloids from the Leaves of Microcos paniculata. J Nat Prod 2022. [PMID: 35171609 DOI: 10.1021/acs.jnatprod.1c00960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Eguchi R, Kawabe J, Wakabayashi I. VEGF-Independent Angiogenic Factors: Beyond VEGF/VEGFR2 Signaling. J Vasc Res. [DOI: 10.1159/000521584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
27 Kim Y, Kim DY, Zhang H, Bae CR, Seong D, Kim Y, Song J, Kim YM, Kwon YG. DIX domain containing 1 (DIXDC1) modulates VEGFR2 level in vasculatures to regulate embryonic and postnatal retina angiogenesis. BMC Biol 2022;20:41. [PMID: 35144597 DOI: 10.1186/s12915-022-01240-3] [Reference Citation Analysis]
28 Lappano R, Todd LA, Stanic M, Cai Q, Maggiolini M, Marincola F, Pietrobon V. Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment. Cancers 2022;14:539. [DOI: 10.3390/cancers14030539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Xu X, Mu L, Li L, Liang J, Zhang S, Jia L, Yang X, Dai Y, Zhang J, Wang Y, Niu S, Xia G, Yang Y, Zhang Y, Cao Y, Zhang H. Imaging and tracing the pattern of adult ovarian angiogenesis implies a strategy against female reproductive aging. Sci Adv 2022;8:eabi8683. [PMID: 35020427 DOI: 10.1126/sciadv.abi8683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Fan Y, He S. The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer. Cancer Manag Res 2022;14:1-17. [PMID: 35018117 DOI: 10.2147/CMAR.S316700] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
31 Starks AO, Owen J, Isaacs J. Evaluation of the Induced Membrane for Neurotrophic Factors. J Hand Surg Am 2021:S0363-5023(21)00598-0. [PMID: 34865951 DOI: 10.1016/j.jhsa.2021.08.023] [Reference Citation Analysis]
32 Ishikawa M, Osaki M, Uno N, Ohira T, Kugoh H, Okada F. MTA1, a metastasis‑associated protein, in endothelial cells is an essential molecule for angiogenesis. Mol Med Rep 2022;25:11. [PMID: 34779499 DOI: 10.3892/mmr.2021.12527] [Reference Citation Analysis]
33 Jia H, Harikumar P, Atkinson E, Rigsby P, Wadhwa M. The First WHO International Standard for Harmonizing the Biological Activity of Bevacizumab. Biomolecules 2021;11:1610. [PMID: 34827607 DOI: 10.3390/biom11111610] [Reference Citation Analysis]
34 Murphy AD, Morgan RD, Clamp AR, Jayson GC. The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancer. Br J Cancer 2021. [PMID: 34716396 DOI: 10.1038/s41416-021-01605-5] [Reference Citation Analysis]
35 Fang JS, Hultgren NW, Hughes CCW. Regulation of Partial and Reversible Endothelial-to-Mesenchymal Transition in Angiogenesis. Front Cell Dev Biol 2021;9:702021. [PMID: 34692672 DOI: 10.3389/fcell.2021.702021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Feng JF, Zhao JM, Yang X, Wang L. The Prognostic Impact of Preoperative Serum Apolipoprotein A-I in Patients with Esophageal Basaloid Squamous Cell Carcinoma. Cancer Manag Res 2021;13:7373-85. [PMID: 34588815 DOI: 10.2147/CMAR.S328138] [Reference Citation Analysis]
37 Wang D, Cheng J, Zhang J, Zhou F, He X, Shi Y, Tao Y. The Role of Respiratory Microbiota in Lung Cancer. Int J Biol Sci 2021;17:3646-58. [PMID: 34512172 DOI: 10.7150/ijbs.51376] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
38 Zhou C, Huang Y, Wu J, Wei Y, Chen X, Lin Z, Nie S. A narrative review of multiple mechanisms of progranulin in cancer: a potential target for anti-cancer therapy. Transl Cancer Res 2021;10:4207-16. [PMID: 35116716 DOI: 10.21037/tcr-20-2972] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Oudart JB, Villemin M, Brassart B, Sellier C, Terryn C, Dupont-Deshorgue A, Monboisse JC, Maquart FX, Ramont L, Brassart-Pasco S. F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction. Cell Adh Migr 2021;15:215-23. [PMID: 34308743 DOI: 10.1080/19336918.2021.1951425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Gatsiou A, Sopova K, Tselepis A, Stellos K. Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State. Cells 2021;10:1855. [PMID: 34440624 DOI: 10.3390/cells10081855] [Reference Citation Analysis]
41 Zhang Y, Coleman M, Brekken RA. Perspectives on Hypoxia Signaling in Tumor Stroma. Cancers (Basel) 2021;13:3070. [PMID: 34202979 DOI: 10.3390/cancers13123070] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
42 Chan LY, Du J, Craik DJ. Tuning the Anti-Angiogenic Effect of the P15 Peptide Using Cyclic Trypsin Inhibitor Scaffolds. ACS Chem Biol 2021;16:829-37. [PMID: 33881318 DOI: 10.1021/acschembio.0c00907] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Ademi H, Shinde DA, Gassmann M, Gerst D, Chaachouay H, Vogel J, Gorr TA. Targeting neovascularization and respiration of tumor grafts grown on chick embryo chorioallantoic membranes. PLoS One 2021;16:e0251765. [PMID: 33999935 DOI: 10.1371/journal.pone.0251765] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
44 Yang Y, Xia L, Wu Y, Zhou H, Chen X, Li H, Xu M, Qi Z, Wang Z, Sun H, Cheng X. Programmed death ligand-1 regulates angiogenesis and metastasis by participating in the c-JUN/VEGFR2 signaling axis in ovarian cancer. Cancer Commun (Lond) 2021;41:511-27. [PMID: 33939321 DOI: 10.1002/cac2.12157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
45 Asiry S, Kim G, Filippou PS, Sanchez LR, Entenberg D, Marks DK, Oktay MH, Karagiannis GS. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy. Front Immunol 2021;12:654877. [PMID: 33927723 DOI: 10.3389/fimmu.2021.654877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
46 Majidpoor J, Mortezaee K. Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr) 2021;44:715-37. [PMID: 33835425 DOI: 10.1007/s13402-021-00602-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
47 Tronolone JJ, Jain A. Engineering new microvascular networks on-chip: ingredients, assembly, and best practices. Adv Funct Mater 2021;31:2007199. [PMID: 33994903 DOI: 10.1002/adfm.202007199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
48 Marcella S, Petraroli A, Braile M, Parente R, Ferrara AL, Galdiero MR, Modestino L, Cristinziano L, Rossi FW, Varricchi G, Triggiani M, de Paulis A, Spadaro G, Loffredo S. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis. Clin Exp Med 2021;21:415-27. [PMID: 33687603 DOI: 10.1007/s10238-021-00693-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Suares A, Medina MV, Coso O. Autophagy in Viral Development and Progression of Cancer. Front Oncol 2021;11:603224. [PMID: 33763351 DOI: 10.3389/fonc.2021.603224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
50 Akiyama M, Ohtsuki S, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Innate and Adaptive Immunity in Giant Cell Arteritis. Front Immunol 2020;11:621098. [PMID: 33717054 DOI: 10.3389/fimmu.2020.621098] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
51 Zhang S, Yang J, Shen L. Extracellular vesicle-mediated regulation of tumor angiogenesis- implications for anti-angiogenesis therapy. J Cell Mol Med 2021;25:2776-85. [PMID: 33586248 DOI: 10.1111/jcmm.16359] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
52 Manini A, Pantoni L. CADASIL from Bench to Bedside: Disease Models and Novel Therapeutic Approaches. Mol Neurobiol 2021;58:2558-73. [PMID: 33464533 DOI: 10.1007/s12035-021-02282-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Han L, Korangath P, Nguyen NK, Diehl A, Cho S, Teo WW, Cope L, Gessler M, Romer L, Sukumar S. HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium. Front Oncol 2020;10:581459. [PMID: 33520697 DOI: 10.3389/fonc.2020.581459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Changchien CY, Chang HH, Dai MS, Tsai WC, Tsai HC, Wang CY, Shen MS, Cheng LT, Lee HS, Chen Y, Tsai CL. Distinct JNK/VEGFR signaling on angiogenesis of breast cancer-associated pleural fluid based on hormone receptor status. Cancer Sci 2021;112:781-91. [PMID: 33315285 DOI: 10.1111/cas.14772] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
55 Markiewski MM, Daugherity E, Reese B, Karbowniczek M. The Role of Complement in Angiogenesis. Antibodies (Basel) 2020;9:E67. [PMID: 33271774 DOI: 10.3390/antib9040067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
56 Li X, Niu N, Sun J, Mou Y, He X, Mei L. IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1. FEBS Open Bio 2020;10:2687-701. [PMID: 33064893 DOI: 10.1002/2211-5463.13005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
57 Hultgren NW, Fang JS, Ziegler ME, Ramirez RN, Phan DTT, Hatch MMS, Welch-Reardon KM, Paniagua AE, Kim LS, Shon NN, Williams DS, Mortazavi A, Hughes CCW. Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis. Nat Commun 2020;11:5400. [PMID: 33106502 DOI: 10.1038/s41467-020-18633-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
58 Wu Z, Yao H, Xu H, Wang Y, Hu W, Lou G, Zhang L, Huang C, Jiang C, Zhou S, Shi Y, Chen X, Yang L, Xu Y, Wang Y. Inhibition of eNOS by L-NAME resulting in rat hind limb developmental defects through PFKFB3 mediated angiogenetic pathway. Sci Rep 2020;10:16754. [PMID: 33028909 DOI: 10.1038/s41598-020-74011-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
59 Yang F, Cohen RN, Brey EM. Optimization of Co-Culture Conditions for a Human Vascularized Adipose Tissue Model. Bioengineering (Basel) 2020;7:E114. [PMID: 32957541 DOI: 10.3390/bioengineering7030114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
60 Allen A, Gau D, Francoeur P, Sturm J, Wang Y, Martin R, Maranchie J, Duensing A, Kaczorowski A, Duensing S, Wu L, Lotze MT, Koes D, Storkus WJ, Roy P. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells. J Biol Chem 2020;295:15636-49. [PMID: 32883810 DOI: 10.1074/jbc.RA120.013963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
61 Furukawa K, Nagano T, Tachihara M, Yamamoto M, Nishimura Y. Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer. Molecules 2020;25:E3900. [PMID: 32859106 DOI: 10.3390/molecules25173900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
62 Wang Z, Xu Q, Zhang N, Du X, Xu G, Yan X. CD146, from a melanoma cell adhesion molecule to a signaling receptor. Signal Transduct Target Ther 2020;5:148. [PMID: 32782280 DOI: 10.1038/s41392-020-00259-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
63 Okuda KS, Hogan BM. Endothelial Cell Dynamics in Vascular Development: Insights From Live-Imaging in Zebrafish. Front Physiol 2020;11:842. [PMID: 32792978 DOI: 10.3389/fphys.2020.00842] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
64 Chen F, Chen N, Yu Y, Cui J. Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Meta-Analysis. Front Oncol 2020;10:904. [PMID: 32714857 DOI: 10.3389/fonc.2020.00904] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
65 Li MY, Fan H, Hu DS. Angiogenesis-promoting factors in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2020; 28(11): 435-442 [DOI: 10.11569/wcjd.v28.i11.435] [Reference Citation Analysis]
66 Peroutka RJ, Buzza MS, Mukhopadhyay S, Johnson TA, Driesbaugh KH, Antalis TM. Testisin/Prss21 deficiency causes increased vascular permeability and a hemorrhagic phenotype during luteal angiogenesis. PLoS One 2020;15:e0234407. [PMID: 32511276 DOI: 10.1371/journal.pone.0234407] [Reference Citation Analysis]
67 Liao Y, Wang C, Yang Z, Liu W, Yuan Y, Li K, Zhang Y, Wang Y, Shi Y, Qiu Y, Zuo D, He W, Qiu J, Guan X, Yuan Y, Li B. Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma. Theranostics 2020;10:5209-24. [PMID: 32373208 DOI: 10.7150/thno.43640] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
68 Roehlecke C, Schmidt MHH. Tunneling Nanotubes and Tumor Microtubes in Cancer. Cancers (Basel) 2020;12:E857. [PMID: 32244839 DOI: 10.3390/cancers12040857] [Cited by in Crossref: 19] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
69 Xie T, Li N, Mao S, Zhang Q, Lin JM. Cell Heterogeneity Revealed by On-Chip Angiogenic Endothelial Cell Migration. ACS Omega 2020;5:3857-62. [PMID: 32149212 DOI: 10.1021/acsomega.9b03074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Zhou C, Yao Q, Zhang H, Guo X, Liu J, Shi Q, Huang S, Xiong B. Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasis. Sci Rep 2020;10:2964. [PMID: 32076049 DOI: 10.1038/s41598-020-59746-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
71 Zhang S, Kim JY, Xu S, Liu H, Yin M, Koroleva M, Guo J, Pei X, Jin ZG. Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ. Proc Natl Acad Sci U S A 2020;117:4792-801. [PMID: 32075915 DOI: 10.1073/pnas.1916198117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
72 Icli B, Li H, Pérez-Cremades D, Wu W, Ozdemir D, Haemmig S, Guimaraes RB, Manica A, Marchini JF, Orgill DP, Feinberg MW. MiR-4674 regulates angiogenesis in tissue injury by targeting p38K signaling in endothelial cells. Am J Physiol Cell Physiol 2020;318:C524-35. [PMID: 31913696 DOI: 10.1152/ajpcell.00542.2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
73 Schirbel A, Rebert N, Sadler T, West G, Rieder F, Wagener C, Horst A, Sturm A, de la Motte C, Fiocchi C. Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy. Inflamm Bowel Dis 2019;25:294-305. [PMID: 30295747 DOI: 10.1093/ibd/izy316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
74 Ghouse SM, Vadrevu SK, Manne S, Reese B, Patel J, Patel B, Silwal A, Lodhi N, Paterson Y, Srivastava SK, Karbowniczek M, Markiewski MM. Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis. J Immunol 2020;204:990-1000. [PMID: 31900334 DOI: 10.4049/jimmunol.1901208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
75 Ye J, Luo QY, Wang XP, Liu ZY, Chen MX, Huang H, Zhang L. Serum Apolipoprotein A-I Combined With C-Reactive Protein Serves As A Novel Prognostic Stratification System For Colorectal Cancer. Cancer Manag Res 2019;11:9265-76. [PMID: 31802946 DOI: 10.2147/CMAR.S215599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
76 Park J, Choi Y, Chang H, Um W, Ryu JH, Kwon IC. Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment. Theranostics 2019;9:8073-90. [PMID: 31754382 DOI: 10.7150/thno.37198] [Cited by in Crossref: 121] [Cited by in F6Publishing: 129] [Article Influence: 40.3] [Reference Citation Analysis]
77 Boraiah V, Modgil S, Sharma K, Podder V, Sivapuram MS, Miranpuri GS, Anand A, Goni V. Altered Expression of Heat Shock Protein-27 and Monocyte Chemoattractant Protein-1 after Acute Spinal Cord Injury: A Pilot Study. J Neurosci Rural Pract 2019;10:452-8. [PMID: 31595117 DOI: 10.1055/s-0039-1697683] [Reference Citation Analysis]
78 Ghorbanian M, Babashah S, Ataei F. The effects of ovarian cancer cell-derived exosomes on vascular endothelial growth factor expression in endothelial cells. EXCLI J 2019;18:899-907. [PMID: 31645849 DOI: 10.17179/excli2019-1800] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
79 Lien JC, Chung CL, Huang TF, Chang TC, Chen KC, Gao GY, Hsu MJ, Huang SW. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling. Br J Pharmacol 2019;176:4034-49. [PMID: 31368127 DOI: 10.1111/bph.14813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
80 Wang Y, Hoeppner LH, Angom RS, Wang E, Dutta S, Doeppler HR, Wang F, Shen T, Scarisbrick IA, Guha S, Storz P, Bhattacharya R, Mukhopadhyay D. Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β. J Biol Chem 2019;294:15759-67. [PMID: 31492751 DOI: 10.1074/jbc.RA119.010152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
81 Wei Z, Volkova E, Blatchley MR, Gerecht S. Hydrogel vehicles for sequential delivery of protein drugs to promote vascular regeneration. Adv Drug Deliv Rev 2019;149-150:95-106. [PMID: 31421149 DOI: 10.1016/j.addr.2019.08.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
82 Wade SM, Ohnesorge N, McLoughlin H, Biniecka M, Carter SP, Trenkman M, Cunningham CC, McGarry T, Canavan M, Kennedy BN, Veale DJ, Fearon U. Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis. EBioMedicine 2019;47:402-13. [PMID: 31466915 DOI: 10.1016/j.ebiom.2019.08.043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
83 Liang H, Wang M. Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer. Cancer Manag Res 2019;11:7707-19. [PMID: 31616186 DOI: 10.2147/CMAR.S212238] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
84 Rouamba A, Compaoré M, Kiendrebeogo M. Molecular targets of honey bee’s products in cancer prevention and treatment. J Herbmed Pharmacol 2019;8:261-8. [DOI: 10.15171/jhp.2019.38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Capuano A, Andreuzzi E, Pivetta E, Doliana R, Favero A, Canzonieri V, Maiero S, Fornasarig M, Magris R, Cannizzaro R, Mongiat M, Spessotto P. The Probe Based Confocal Laser Endomicroscopy (pCLE) in Locally Advanced Gastric Cancer: A Powerful Technique for Real-Time Analysis of Vasculature. Front Oncol 2019;9:513. [PMID: 31263680 DOI: 10.3389/fonc.2019.00513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
86 Szklanny AA, Debbi L, Merdler U, Neale D, Muñiz A, Kaplan B, Guo S, Lahann J, Levenberg S. High‐Throughput Scaffold System for Studying the Effect of Local Geometry and Topology on the Development and Orientation of Sprouting Blood Vessels. Adv Funct Mater 2020;30:1901335. [DOI: 10.1002/adfm.201901335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
87 Asawaeer M, Barton D, Radio S, Chatzizisis YS. Tyrosine Kinase Inhibitor-Induced Acute Myocarditis, Myositis, and Cardiogenic Shock. Methodist Debakey Cardiovasc J 2018;14:e5-6. [PMID: 30410662 DOI: 10.14797/mdcj-14-3-e5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
88 Icli B, Wu W, Ozdemir D, Li H, Cheng HS, Haemmig S, Liu X, Giatsidis G, Avci SN, Lee N, Guimaraes RB, Manica A, Marchini JF, Rynning SE, Risnes I, Hollan I, Croce K, Yang X, Orgill DP, Feinberg MW. MicroRNA-615-5p Regulates Angiogenesis and Tissue Repair by Targeting AKT/eNOS (Protein Kinase B/Endothelial Nitric Oxide Synthase) Signaling in Endothelial Cells. Arterioscler Thromb Vasc Biol 2019;39:1458-74. [PMID: 31092013 DOI: 10.1161/ATVBAHA.119.312726] [Cited by in Crossref: 30] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
89 Stryker ZI, Rajabi M, Davis PJ, Mousa SA. Evaluation of Angiogenesis Assays. Biomedicines 2019;7:E37. [PMID: 31100863 DOI: 10.3390/biomedicines7020037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
90 Alasvand M, Assadollahi V, Ambra R, Hedayati E, Kooti W, Peluso I. Antiangiogenic Effect of Alkaloids. Oxid Med Cell Longev 2019;2019:9475908. [PMID: 31178979 DOI: 10.1155/2019/9475908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
91 Sircana A, Paschetta E, Saba F, Molinaro F, Musso G. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Int J Mol Sci 2019;20:E1745. [PMID: 30970564 DOI: 10.3390/ijms20071745] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
92 Mongiardi MP, Radice G, Piras M, Stagni V, Pacioni S, Re A, Putti S, Ferrè F, Farsetti A, Pallini R, Barilà D, Levi A, Falchetti ML. Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation. Oncogene 2019;38:5413-24. [PMID: 30967634 DOI: 10.1038/s41388-019-0798-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
93 Schaaf MB, Houbaert D, Meçe O, To SK, Ganne M, Maes H, Agostinis P. Lysosomal Pathways and Autophagy Distinctively Control Endothelial Cell Behavior to Affect Tumor Vasculature. Front Oncol 2019;9:171. [PMID: 30949450 DOI: 10.3389/fonc.2019.00171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
94 Costea T, Nagy P, Ganea C, Szöllősi J, Mocanu MM. Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer. Int J Mol Sci 2019;20:E1062. [PMID: 30823649 DOI: 10.3390/ijms20051062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
95 Aghaabdollahian S, Ahangari Cohan R, Norouzian D, Davami F, Asadi Karam MR, Torkashvand F, Vaseghi G, Moazzami R, Latif Dizaji S. Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology. Sci Rep 2019;9:2978. [PMID: 30814652 DOI: 10.1038/s41598-019-39776-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
96 Kim HN, Habbit NL, Su C, Choi N, Ahn EH, Lipke EA, Kim D. Microphysiological Systems as Enabling Tools for Modeling Complexity in the Tumor Microenvironment and Accelerating Cancer Drug Development. Adv Funct Mater 2019;29:1807553. [DOI: 10.1002/adfm.201807553] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
97 MacKeil JL, Brzezinska P, Burke-Kleinman J, Craig AW, Nicol CJB, Maurice DH. A PKA/cdc42 Signaling Axis Restricts Angiogenic Sprouting by Regulating Podosome Rosette Biogenesis and Matrix Remodeling. Sci Rep 2019;9:2385. [PMID: 30787359 DOI: 10.1038/s41598-018-37805-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
98 Schaaf MB, Houbaert D, Meçe O, Agostinis P. Autophagy in endothelial cells and tumor angiogenesis. Cell Death Differ 2019;26:665-79. [PMID: 30692642 DOI: 10.1038/s41418-019-0287-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 70] [Article Influence: 16.3] [Reference Citation Analysis]
99 Icli B, Wu W, Ozdemir D, Li H, Haemmig S, Liu X, Giatsidis G, Cheng HS, Avci SN, Kurt M, Lee N, Guimaraes RB, Manica A, Marchini JF, Rynning SE, Risnes I, Hollan I, Croce K, Orgill DP, Feinberg MW. MicroRNA-135a-3p regulates angiogenesis and tissue repair by targeting p38 signaling in endothelial cells. FASEB J 2019;33:5599-614. [PMID: 30668922 DOI: 10.1096/fj.201802063RR] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
100 Georganaki M, van Hooren L, Dimberg A. Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer. Front Immunol 2018;9:3081. [PMID: 30627131 DOI: 10.3389/fimmu.2018.03081] [Cited by in Crossref: 40] [Cited by in F6Publishing: 58] [Article Influence: 10.0] [Reference Citation Analysis]
101 He W, Yan J, Sui F, Wang S, Su X, Qu Y, Yang Q, Guo H, Ji M, Lu W, Shao Y, Hou P. Turning a Luffa Protein into a Self-Assembled Biodegradable Nanoplatform for Multitargeted Cancer Therapy. ACS Nano 2018;12:11664-77. [PMID: 30335959 DOI: 10.1021/acsnano.8b07079] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
102 Fernandes C, Suares D, Yergeri MC. Tumor Microenvironment Targeted Nanotherapy. Front Pharmacol 2018;9:1230. [PMID: 30429787 DOI: 10.3389/fphar.2018.01230] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 14.0] [Reference Citation Analysis]
103 Zhang Y, Kirane A, Huang H, Sorrelle NB, Burrows FJ, Dellinger MT, Brekken RA. Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer. Mol Cancer Res 2019;17:348-55. [PMID: 30333153 DOI: 10.1158/1541-7786.MCR-18-0427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
104 Perry L, Landau S, Flugelman MY, Levenberg S. Genetically engineered human muscle transplant enhances murine host neovascularization and myogenesis. Commun Biol 2018;1:161. [PMID: 30320229 DOI: 10.1038/s42003-018-0161-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
105 Gallo S, Arcidiacono MV, Tisato V, Piva R, Penolazzi L, Bosi C, Feo CV, Gafà R, Secchiero P. Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature. Onco Targets Ther 2018;11:6049-56. [PMID: 30275709 DOI: 10.2147/OTT.S171678] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
106 Santos J, Brito M, Ferreira R, Moura AP, Sousa T, Batista T, Mangueira V, Leite F, Cruz R, Vieira G, Lira B, Athayde-Filho P, Souza H, Costa N, Veras R, Barbosa-Filho JM, Magalhães H, Sobral M. Th1-Biased Immunomodulation and In Vivo Antitumor Effect of a Novel Piperine Analogue. Int J Mol Sci 2018;19:E2594. [PMID: 30200386 DOI: 10.3390/ijms19092594] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
107 Landau S, Ben-Shaul S, Levenberg S. Oscillatory Strain Promotes Vessel Stabilization and Alignment through Fibroblast YAP-Mediated Mechanosensitivity. Adv Sci (Weinh) 2018;5:1800506. [PMID: 30250793 DOI: 10.1002/advs.201800506] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
108 Nguyen EH, Murphy WL. Customizable biomaterials as tools for advanced anti-angiogenic drug discovery. Biomaterials 2018;181:53-66. [PMID: 30077137 DOI: 10.1016/j.biomaterials.2018.07.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
109 Draoui N, de Zeeuw P, Carmeliet P. Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism. Open Biol 2017;7:170219. [PMID: 29263247 DOI: 10.1098/rsob.170219] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 13.3] [Reference Citation Analysis]
110 Lu J, Liu QH, Wang F, Tan JJ, Deng YQ, Peng XH, Liu X, Zhang B, Xu X, Li XP. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2018;37:147. [PMID: 30001734 DOI: 10.1186/s13046-018-0814-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 86] [Article Influence: 13.3] [Reference Citation Analysis]
111 Suffredini DA, Lee JM, Peer CJ, Pratt D, Kleiner DE, Elinoff JM, Solomon MA. Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab. BMC Pulm Med 2018;18:112. [PMID: 29996818 DOI: 10.1186/s12890-018-0681-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
112 Wang P, Zhu S, Yuan C, Wang L, Xu J, Liu Z. Shear stress promotes differentiation of stem cells from human exfoliated deciduous teeth into endothelial cells via the downstream pathway of VEGF-Notch signaling. Int J Mol Med. 2018;42:1827-1836. [PMID: 30015843 DOI: 10.3892/ijmm.2018.3761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
113 Campbell KR, Yau C. Uncovering pseudotemporal trajectories with covariates from single cell and bulk expression data. Nat Commun 2018;9:2442. [PMID: 29934517 DOI: 10.1038/s41467-018-04696-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
114 Ramaker RC, Lasseigne BN, Hardigan AA, Palacio L, Gunther DS, Myers RM, Cooper SJ. RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature. Oncotarget 2017;8:38668-81. [PMID: 28454104 DOI: 10.18632/oncotarget.16961] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
115 Li T, Kang G, Wang T, Huang H. Tumor angiogenesis and anti-angiogenic gene therapy for cancer. Oncol Lett 2018;16:687-702. [PMID: 29963134 DOI: 10.3892/ol.2018.8733] [Cited by in Crossref: 27] [Cited by in F6Publishing: 71] [Article Influence: 6.8] [Reference Citation Analysis]
116 Kordbacheh F, Carruthers TJ, Bezos A, Oakes M, Du Fall L, Hocart CH, Parish CR, Djordjevic MA. Promotion of mammalian angiogenesis by neolignans derived from soybean extracellular fluids. PLoS One 2018;13:e0196843. [PMID: 29738532 DOI: 10.1371/journal.pone.0196843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Wen Z, Shen Y, Berry G, Shahram F, Li Y, Watanabe R, Liao YJ, Goronzy JJ, Weyand CM. The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway. Sci Transl Med 2017;9:eaal3322. [PMID: 28724574 DOI: 10.1126/scitranslmed.aal3322] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 10.5] [Reference Citation Analysis]
118 Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, Horninger W, Gastl G, Zelger B, Brunner A, Pichler R. High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma. Cancer Sci 2018;109:1583-91. [PMID: 29498788 DOI: 10.1111/cas.13560] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
119 Alessandra-Perini J, Perini JA, Rodrigues-Baptista KC, de Moura RS, Junior AP, Dos Santos TA, Souza PJC, Nasciutti LE, Machado DE. Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer. BMC Complement Altern Med 2018;18:116. [PMID: 29609579 DOI: 10.1186/s12906-018-2183-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
120 Yamamoto T, Kosaka N, Hattori Y, Ochiya T. A Challenge to Aging Society by microRNA in Extracellular Vesicles: microRNA in Extracellular Vesicles as Promising Biomarkers and Novel Therapeutic Targets in Multiple Myeloma. J Clin Med 2018;7:E55. [PMID: 29534557 DOI: 10.3390/jcm7030055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
121 Yamakawa M, Doh SJ, Santosa SM, Montana M, Qin EC, Kong H, Han KY, Yu C, Rosenblatt MI, Kazlauskas A, Chang JH, Azar DT. Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review. Med Res Rev 2018;38:1769-98. [PMID: 29528507 DOI: 10.1002/med.21496] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
122 Varricchi G, Ameri P, Cadeddu C, Ghigo A, Madonna R, Marone G, Mercurio V, Monte I, Novo G, Parrella P, Pirozzi F, Pecoraro A, Spallarossa P, Zito C, Mercuro G, Pagliaro P, Tocchetti CG. Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective. Front Physiol 2018;9:167. [PMID: 29563880 DOI: 10.3389/fphys.2018.00167] [Cited by in Crossref: 53] [Cited by in F6Publishing: 70] [Article Influence: 13.3] [Reference Citation Analysis]
123 Jacob L, Sawma P, Garnier N, Meyer LA, Fritz J, Hussenet T, Spenlé C, Goetz J, Vermot J, Fernandez A, Baumlin N, Aci-Sèche S, Orend G, Roussel G, Crémel G, Genest M, Hubert P, Bagnard D. Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide. Oncotarget 2016;7:57851-65. [PMID: 27506939 DOI: 10.18632/oncotarget.11072] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
124 Faes S, Uldry E, Planche A, Santoro T, Pythoud C, Demartines N, Dormond O. Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies. Oncotarget 2016;7:86026-38. [PMID: 27852069 DOI: 10.18632/oncotarget.13323] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
125 Ulivi P, Marisi G, Passardi A. Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer. Oncotarget 2016;7:46678-91. [PMID: 27081084 DOI: 10.18632/oncotarget.8712] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
126 Schaaf MB, Garg AD, Agostinis P. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy. Cell Death Dis 2018;9:115. [PMID: 29371595 DOI: 10.1038/s41419-017-0061-0] [Cited by in Crossref: 177] [Cited by in F6Publishing: 249] [Article Influence: 44.3] [Reference Citation Analysis]
127 Landau S, Guo S, Levenberg S. Localization of Engineered Vasculature within 3D Tissue Constructs. Front Bioeng Biotechnol 2018;6:2. [PMID: 29404324 DOI: 10.3389/fbioe.2018.00002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
128 Pircher A, Jöhrer K, Kocher F, Steiner N, Graziadei I, Heidegger I, Pichler R, Leonhartsberger N, Kremser C, Kern J, Untergasser G, Gunsilius E, Hilbe W. Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies. Oncotarget 2016;7:20109-23. [PMID: 26956051 DOI: 10.18632/oncotarget.7915] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
129 Rahbari NN, Kedrin D, Incio J, Liu H, Ho WW, Nia HT, Edrich CM, Jung K, Daubriac J, Chen I, Heishi T, Martin JD, Huang Y, Maimon N, Reissfelder C, Weitz J, Boucher Y, Clark JW, Grodzinsky AJ, Duda DG, Jain RK, Fukumura D. Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases. Sci Transl Med. 2016;8:360ra135. [PMID: 27733559 DOI: 10.1126/scitranslmed.aaf5219] [Cited by in Crossref: 103] [Cited by in F6Publishing: 125] [Article Influence: 20.6] [Reference Citation Analysis]
130 Urabe F, Kosaka N, Yoshioka Y, Egawa S, Ochiya T. The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatment. Clin Transl Med 2017;6:45. [PMID: 29238879 DOI: 10.1186/s40169-017-0176-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
131 Kazokaitė J, Aspatwar A, Parkkila S, Matulis D. An update on anticancer drug development and delivery targeting carbonic anhydrase IX. PeerJ 2017;5:e4068. [PMID: 29181278 DOI: 10.7717/peerj.4068] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
132 Antila S, Karaman S, Nurmi H, Airavaara M, Voutilainen MH, Mathivet T, Chilov D, Li Z, Koppinen T, Park JH, Fang S, Aspelund A, Saarma M, Eichmann A, Thomas JL, Alitalo K. Development and plasticity of meningeal lymphatic vessels. J Exp Med 2017;214:3645-67. [PMID: 29141865 DOI: 10.1084/jem.20170391] [Cited by in Crossref: 155] [Cited by in F6Publishing: 168] [Article Influence: 31.0] [Reference Citation Analysis]
133 Lin CY, Cho CF, Bai ST, Liu JP, Kuo TT, Wang LJ, Lin YS, Lin CC, Lai LC, Lu TP, Hsieh CY, Chu CN, Cheng DC, Sher YP. ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT. Sci Rep 2017;7:15108. [PMID: 29118335 DOI: 10.1038/s41598-017-15159-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
134 Pircher A, Wolf D, Heidenreich A, Hilbe W, Pichler R, Heidegger I. Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality. Int J Mol Sci 2017;18:E2291. [PMID: 29088109 DOI: 10.3390/ijms18112291] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
135 Canela MD, Noppen S, Bueno O, Prota AE, Bargsten K, Sáez-Calvo G, Jimeno ML, Benkheil M, Ribatti D, Velázquez S, Camarasa MJ, Díaz JF, Steinmetz MO, Priego EM, Pérez-Pérez MJ, Liekens S. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091. Oncotarget 2017;8:14325-42. [PMID: 27224920 DOI: 10.18632/oncotarget.9527] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
136 Mikuła-Pietrasik J, Uruski P, Szubert S, Maksin K, Moszyński R, Szpurek D, Woźniak A, Sajdak S, Tykarski A, Książek K. The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors. Biomed Res Int 2017;2017:2592496. [PMID: 29085834 DOI: 10.1155/2017/2592496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
137 Pan CC, Shah N, Kumar S, Wheeler SE, Cinti J, Hoyt DG, Beattie CE, An M, Mythreye K, Rakotondraibe LH, Lee NY. Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy. Oncotarget 2017;8:12675-85. [PMID: 27177332 DOI: 10.18632/oncotarget.9307] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
138 Kim J, Mirando AC, Popel AS, Green JJ. Gene delivery nanoparticles to modulate angiogenesis. Adv Drug Deliv Rev 2017;119:20-43. [PMID: 27913120 DOI: 10.1016/j.addr.2016.11.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
139 Du YE, Tu G, Yang G, Li G, Yang D, Lang L, Xi L, Sun K, Chen Y, Shu K, Liao H, Liu M, Hou Y. MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling. Theranostics 2017;7:3972-88. [PMID: 29109792 DOI: 10.7150/thno.18990] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 11.8] [Reference Citation Analysis]
140 Wang Z, Liu T. Placental growth factor signaling regulates isoform splicing of vascular endothelial growth factor A in the control of lung cancer cell metastasis. Mol Cell Biochem 2018;439:163-9. [PMID: 28861767 DOI: 10.1007/s11010-017-3145-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
141 Pichler R, Heidegger I. Novel concepts of antiangiogenic therapies in metastatic renal cell cancer. Memo 2017;10:206-12. [PMID: 29250198 DOI: 10.1007/s12254-017-0344-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
142 Tseng JC, Narayanan N, Ho G, Groves K, Delaney J, Bao B, Zhang J, Morin J, Kossodo S, Rajopadhye M. Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism. PLoS One. 2017;12:e0182689. [PMID: 28792505 DOI: 10.1371/journal.pone.0182689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
143 Gao P, Niu N, Wei T, Tozawa H, Chen X, Zhang C, Zhang J, Wada Y, Kapron CM, Liu J. The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis. Oncotarget 2017;8:69139-61. [PMID: 28978186 DOI: 10.18632/oncotarget.19932] [Cited by in Crossref: 36] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
144 Mazzuca P, Marsico S, Schulze K, Mitola S, Pils MC, Giagulli C, Guzman CA, Caruso A, Caccuri F. Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. J Virol 2017;91:e00801-17. [PMID: 28592537 DOI: 10.1128/JVI.00801-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
145 Peters EB. Endothelial Progenitor Cells for the Vascularization of Engineered Tissues. Tissue Eng Part B Rev 2018;24:1-24. [PMID: 28548628 DOI: 10.1089/ten.TEB.2017.0127] [Cited by in Crossref: 64] [Cited by in F6Publishing: 83] [Article Influence: 12.8] [Reference Citation Analysis]
146 Feng T, Yu H, Xia Q, Ma Y, Yin H, Shen Y, Liu X. Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration. Oncotarget 2017;8:69577-93. [PMID: 29050226 DOI: 10.18632/oncotarget.18632] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
147 Wang D, Tan C, Xiao F, Zou L, Wang L, Wei Y, Yang H, Zhang W. The "inherent vice" in the anti-angiogenic theory may cause the highly metastatic cancer to spread more aggressively. Sci Rep 2017;7:2365. [PMID: 28539645 DOI: 10.1038/s41598-017-02534-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
148 Chen Y, Zhang L. Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med 2017;14:10-7. [PMID: 28672887 DOI: 10.3892/etm.2017.4488] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
149 Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat Rev Drug Discov 2017;16:635-61. [PMID: 28529319 DOI: 10.1038/nrd.2016.278] [Cited by in Crossref: 176] [Cited by in F6Publishing: 196] [Article Influence: 35.2] [Reference Citation Analysis]
150 Tocchetti CG, Cadeddu C, Di Lisi D, Femminò S, Madonna R, Mele D, Monte I, Novo G, Penna C, Pepe A, Spallarossa P, Varricchi G, Zito C, Pagliaro P, Mercuro G. From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview. Antioxid Redox Signal 2019;30:2110-53. [PMID: 28398124 DOI: 10.1089/ars.2016.6930] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 13.2] [Reference Citation Analysis]
151 Matsushita J, Inagaki S, Nishie T, Sakasai T, Tanaka J, Watanabe C, Mizutani KI, Miwa Y, Matsumoto K, Takara K, Naito H, Kidoya H, Takakura N, Nagai T, Takahashi S, Ema M. Fluorescence and Bioluminescence Imaging of Angiogenesis in Flk1-Nano-lantern Transgenic Mice. Sci Rep 2017;7:46597. [PMID: 28425492 DOI: 10.1038/srep46597] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
152 Perry L, Flugelman MY, Levenberg S. Elderly Patient-Derived Endothelial Cells for Vascularization of Engineered Muscle. Mol Ther 2017;25:935-48. [PMID: 28279644 DOI: 10.1016/j.ymthe.2017.02.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
153 Pant K, Sedláček O, Nadar RA, Hrubý M, Stephan H. Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? Adv Healthc Mater 2017;6. [PMID: 28218487 DOI: 10.1002/adhm.201601115] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
154 Kim TK, Park CS, Na HJ, Lee K, Yoon A, Chung J, Lee S. Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesis. Exp Mol Med 2017;49:e294. [PMID: 28209985 DOI: 10.1038/emm.2016.147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
155 Cantelmo AR, Pircher A, Kalucka J, Carmeliet P. Vessel pruning or healing: endothelial metabolism as a novel target? Expert Opin Ther Targets 2017;21:239-47. [PMID: 28081641 DOI: 10.1080/14728222.2017.1282465] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
156 Roldán S, Cardona A, Conesa L, Murga J, Falomir E, Carda M, Marco JA. Synthesis and biological evaluation of simplified pironetin analogues with modifications in the side chain and the lactone ring. Org Biomol Chem 2017;15:220-32. [DOI: 10.1039/c6ob01585a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
157 Dore-Savard L, Lee E, Kakkad S, Popel AS, Bhujwalla ZM. The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts. Sci Rep 2016;6:39460. [PMID: 27995973 DOI: 10.1038/srep39460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
158 Wang W, Gu Q, Xu X, Zheng Y. A PlGF-1 Derived Peptide Inhibits Angiogenesis via HIF-1β/VEGF Pathway. Int J Pept Res Ther 2017;23:343-55. [DOI: 10.1007/s10989-016-9567-z] [Reference Citation Analysis]
159 Paschali AN, Nekolla SG, Evangelou K, Cook GJ, Anagnostopoulos CD. One Coin, No Need to Flip: Shared PET Targets in Cancer and Coronary Artery Disease. AJR Am J Roentgenol 2017;208:434-45. [PMID: 27897437 DOI: 10.2214/AJR.16.16599] [Reference Citation Analysis]
160 Fu W, Zhuo J, Hu L. Differential effects of recombinant human endostatin treatment on differentiated and undifferentiated blood vessels in Lewis lung cancer. Oncol Lett 2017;13:196-200. [PMID: 28123541 DOI: 10.3892/ol.2016.5446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
161 Mirando AC, Abdi K, Wo P, Lounsbury KM. Assessing the effects of threonyl-tRNA synthetase on angiogenesis-related responses. Methods 2017;113:132-8. [PMID: 27847344 DOI: 10.1016/j.ymeth.2016.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
162 Kim J, Kim J, Bae JS. ROS homeostasis and metabolism: a critical liaison for cancer therapy. Exp Mol Med 2016;48:e269. [PMID: 27811934 DOI: 10.1038/emm.2016.119] [Cited by in Crossref: 120] [Cited by in F6Publishing: 149] [Article Influence: 20.0] [Reference Citation Analysis]
163 Olfert IM. Physiological Capillary Regression is not Dependent on Reducing VEGF Expression. Microcirculation 2016;23:146-56. [PMID: 26660949 DOI: 10.1111/micc.12263] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
164 Huang L, Couto JA, Pinto A, Alexandrescu S, Madsen JR, Greene AK, Sahin M, Bischoff J. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome. Pediatr Neurol 2017;67:59-63. [PMID: 27919468 DOI: 10.1016/j.pediatrneurol.2016.10.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
165 Chan LY, Craik DJ, Daly NL. Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy. Sci Rep 2016;6:35347. [PMID: 27734947 DOI: 10.1038/srep35347] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
166 Wang Y, Yin D, Xu C, Wang K, Zheng L, Zhang Y. Roxarsone induces angiogenesis via PI3K/Akt signaling. Cell Biosci 2016;6:54. [PMID: 27708768 DOI: 10.1186/s13578-016-0119-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
167 Scholz A, Harter PN, Cremer S, Yalcin BH, Gurnik S, Yamaji M, Di Tacchio M, Sommer K, Baumgarten P, Bähr O, Steinbach JP, Trojan J, Glas M, Herrlinger U, Krex D, Meinhardt M, Weyerbrock A, Timmer M, Goldbrunner R, Deckert M, Braun C, Schittenhelm J, Frueh JT, Ullrich E, Mittelbronn M, Plate KH, Reiss Y. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med 2016;8:39-57. [PMID: 26666269 DOI: 10.15252/emmm.201505505] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 14.3] [Reference Citation Analysis]
168 Maj E, Papiernik D, Wietrzyk J. Antiangiogenic cancer treatment: The great discovery and greater complexity (Review). Int J Oncol 2016;49:1773-84. [PMID: 27826619 DOI: 10.3892/ijo.2016.3709] [Cited by in Crossref: 62] [Cited by in F6Publishing: 75] [Article Influence: 10.3] [Reference Citation Analysis]
169 Liang J, Liu X, Xie Q, Chen G, Li X, Jia Y, Yin B, Qu X, Li Y. Endostatin enhances antitumor effect of tumor antigen-pulsed dendritic cell therapy in mouse xenograft model of lung carcinoma. Chin J Cancer Res 2016;28:452-60. [PMID: 27647974 DOI: 10.21147/j.issn.1000-9604.2016.04.09] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
170 Stellos K, Gatsiou A, Stamatelopoulos K, Perisic Matic L, John D, Lunella FF, Jaé N, Rossbach O, Amrhein C, Sigala F, Boon RA, Fürtig B, Manavski Y, You X, Uchida S, Keller T, Boeckel JN, Franco-Cereceda A, Maegdefessel L, Chen W, Schwalbe H, Bindereif A, Eriksson P, Hedin U, Zeiher AM, Dimmeler S. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nat Med 2016;22:1140-50. [PMID: 27595325 DOI: 10.1038/nm.4172] [Cited by in Crossref: 133] [Cited by in F6Publishing: 140] [Article Influence: 22.2] [Reference Citation Analysis]
171 Han Q, Bing W, Di Y, Hua L, Shi-He L, Yu-Hua Z, Xiu-Guo H, Yu-Gang W, Qi-Ming F, Shih-Mo Y, Ting-Ting T. Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells. Cell Death Dis 2016;7:e2350. [PMID: 27584788 DOI: 10.1038/cddis.2016.255] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
172 Naito Y, Yoshioka Y, Yamamoto Y, Ochiya T. How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol Life Sci 2017;74:697-713. [PMID: 27582126 DOI: 10.1007/s00018-016-2346-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 89] [Article Influence: 12.8] [Reference Citation Analysis]
173 Kalucka J, Missiaen R, Georgiadou M, Schoors S, Lange C, De Bock K, Dewerchin M, Carmeliet P. Metabolic control of the cell cycle. Cell Cycle 2015;14:3379-88. [PMID: 26431254 DOI: 10.1080/15384101.2015.1090068] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
174 Elks PM, Renshaw SA, Meijer AH, Walmsley SR, van Eeden FJ. Exploring the HIFs, buts and maybes of hypoxia signalling in disease: lessons from zebrafish models. Dis Model Mech 2015;8:1349-60. [PMID: 26512123 DOI: 10.1242/dmm.021865] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
175 Goi T, Nakazawa T, Hirono Y, Yamaguchi A. The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1). Oncotarget 2015;6:28790-9. [PMID: 26318037 DOI: 10.18632/oncotarget.4744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
176 Yang WJ, Hu J, Uemura A, Tetzlaff F, Augustin HG, Fischer A. Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis. EMBO Mol Med 2015;7:1267-84. [PMID: 26194913 DOI: 10.15252/emmm.201404922] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 11.0] [Reference Citation Analysis]
177 Legeay S, Clere N, Hilairet G, Do QT, Bernard P, Quignard JF, Apaire-Marchais V, Lapied B, Faure S. The insect repellent N,N-diethyl-m-toluamide (DEET) induces angiogenesis via allosteric modulation of the M3 muscarinic receptor in endothelial cells. Sci Rep 2016;6:28546. [PMID: 27345502 DOI: 10.1038/srep28546] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
178 Eguchi R, Nakano T, Wakabayashi I. Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells. Oncogene 2017;36:714-22. [PMID: 27345409 DOI: 10.1038/onc.2016.226] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
179 Richards D, Jia J, Yost M, Markwald R, Mei Y. 3D Bioprinting for Vascularized Tissue Fabrication. Ann Biomed Eng 2017;45:132-47. [PMID: 27230253 DOI: 10.1007/s10439-016-1653-z] [Cited by in Crossref: 110] [Cited by in F6Publishing: 110] [Article Influence: 18.3] [Reference Citation Analysis]
180 Madonna R, Cadeddu C, Deidda M, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Spallarossa P, Tocchetti CG, Zito C, Mercuro G. Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection. Heart Fail Rev 2015;20:621-31. [PMID: 26168714 DOI: 10.1007/s10741-015-9497-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
181 Allen E, Miéville P, Warren CM, Saghafinia S, Li L, Peng MW, Hanahan D. Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling. Cell Rep 2016;15:1144-60. [PMID: 27134166 DOI: 10.1016/j.celrep.2016.04.029] [Cited by in Crossref: 127] [Cited by in F6Publishing: 126] [Article Influence: 21.2] [Reference Citation Analysis]
182 Haemmerle M, Bottsford-Miller J, Pradeep S, Taylor ML, Choi HJ, Hansen JM, Dalton HJ, Stone RL, Cho MS, Nick AM, Nagaraja AS, Gutschner T, Gharpure KM, Mangala LS, Rupaimoole R, Han HD, Zand B, Armaiz-Pena GN, Wu SY, Pecot CV, Burns AR, Lopez-Berestein G, Afshar-Kharghan V, Sood AK. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest 2016;126:1885-96. [PMID: 27064283 DOI: 10.1172/JCI85086] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]
183 Helfinger V, Henke N, Harenkamp S, Walter M, Epah J, Penski C, Mittelbronn M, Schröder K. The NADPH Oxidase Nox4 mediates tumour angiogenesis. Acta Physiol (Oxf) 2016;216:435-46. [PMID: 26513738 DOI: 10.1111/apha.12625] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
184 McDonald PC, Chafe SC, Dedhar S. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction. Front Cell Dev Biol 2016;4:27. [PMID: 27066484 DOI: 10.3389/fcell.2016.00027] [Cited by in Crossref: 59] [Cited by in F6Publishing: 78] [Article Influence: 9.8] [Reference Citation Analysis]
185 Rosenfeld D, Landau S, Shandalov Y, Raindel N, Freiman A, Shor E, Blinder Y, Vandenburgh HH, Mooney DJ, Levenberg S. Morphogenesis of 3D vascular networks is regulated by tensile forces. Proc Natl Acad Sci U S A 2016;113:3215-20. [PMID: 26951667 DOI: 10.1073/pnas.1522273113] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
186 Al-Hilal TA, Chung SW, Choi JU, Alam F, Park J, Kim SW, Kim SY, Ahsan F, Kim IS, Byun Y. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis. J Clin Invest 2016;126:1251-66. [PMID: 26950422 DOI: 10.1172/JCI83427] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
187 Ben-Batalla I, Cubas-Cordova M, Udonta F, Wroblewski M, Waizenegger JS, Janning M, Sawall S, Gensch V, Zhao L, Martinez-Zubiaurre I, Riecken K, Fehse B, Pantel K, Bokemeyer C, Loges S. Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget 2015;6:6341-58. [PMID: 25849942 DOI: 10.18632/oncotarget.3437] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
188 Chuang JY, Chen PC, Tsao CW, Chang AC, Lein MY, Lin CC, Wang SW, Lin CW, Tang CH. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression. Oncotarget 2015;6:4239-52. [PMID: 25738362 DOI: 10.18632/oncotarget.2978] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
189 Ricard-Blum S, Vallet SD. Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells. Front Pharmacol 2016;7:11. [PMID: 26869928 DOI: 10.3389/fphar.2016.00011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
190 Vaeteewoottacharn K, Kariya R, Dana P, Fujikawa S, Matsuda K, Ohkuma K, Kudo E, Kraiklang R, Wongkham C, Wongkham S, Okada S. Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma. Tumour Biol 2016;37:9023-35. [PMID: 26762407 DOI: 10.1007/s13277-016-4785-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
191 Wang Y, Tadjuidje E, Pandey RN, Stefater JA 3rd, Smith LE, Lang RA, Hegde RS. The Eyes Absent Proteins in Developmental and Pathological Angiogenesis. Am J Pathol 2016;186:568-78. [PMID: 26765957 DOI: 10.1016/j.ajpath.2015.10.031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
192 Craven KE, Gore J, Korc M. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma. Cancer Lett 2016;381:201-10. [PMID: 26723874 DOI: 10.1016/j.canlet.2015.11.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
193 McIntyre A, Harris AL. Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality. EMBO Mol Med 2015;7:368-79. [PMID: 25700172 DOI: 10.15252/emmm.201404271] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 14.9] [Reference Citation Analysis]
194 Lee E, Song HG, Chen CS. Biomimetic on-a-chip platforms for studying cancer metastasis. Curr Opin Chem Eng 2016;11:20-7. [PMID: 27570735 DOI: 10.1016/j.coche.2015.12.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
195 Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, Gadish O, Sabbisetti V, Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, R Edelman E, Sengupta S. Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nat Commun 2015;6:8671. [PMID: 26669454 DOI: 10.1038/ncomms9671] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
196 Wasserstrum Y, Kornowski R, Raanani P, Leader A, Pasvolsky O, Iakobishvili Z. Hypertension in cancer patients treated with anti-angiogenic based regimens. Cardiooncology 2015;1:6. [PMID: 33530150 DOI: 10.1186/s40959-015-0009-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
197 Sanhueza C, Wehinger S, Castillo Bennett J, Valenzuela M, Owen GI, Quest AF. The twisted survivin connection to angiogenesis. Mol Cancer 2015;14:198. [PMID: 26584646 DOI: 10.1186/s12943-015-0467-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
198 Gaascht F, Dicato M, Diederich M. Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer. Genes Nutr 2015;10:51. [PMID: 26577824 DOI: 10.1007/s12263-015-0501-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
199 Zhang H, Zhou X, Xu C, Yang J, Xiang J, Tao M, Xie Y. Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer. Cancer Gene Ther 2016;23:13-23. [PMID: 26564429 DOI: 10.1038/cgt.2015.59] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
200 Niendorf T, Pohlmann A, Reimann HM, Waiczies H, Peper E, Huelnhagen T, Seeliger E, Schreiber A, Kettritz R, Strobel K, Ku MC, Waiczies S. Advancing Cardiovascular, Neurovascular, and Renal Magnetic Resonance Imaging in Small Rodents Using Cryogenic Radiofrequency Coil Technology. Front Pharmacol 2015;6:255. [PMID: 26617515 DOI: 10.3389/fphar.2015.00255] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
201 Lund AW, Medler TR, Leachman SA, Coussens LM. Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer. Cancer Discov 2016;6:22-35. [PMID: 26552413 DOI: 10.1158/2159-8290.CD-15-0023] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
202 He XR, Han SY, Li PP. Recent highlights of experimental research for inhibiting tumor growth by using Chinese medicine. Chin J Integr Med 2015;21:727-32. [PMID: 26525545 DOI: 10.1007/s11655-015-2318-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
203 Unger RE, Dohle E, Kirkpatrick CJ. Improving vascularization of engineered bone through the generation of pro-angiogenic effects in co-culture systems. Adv Drug Deliv Rev 2015;94:116-25. [PMID: 25817732 DOI: 10.1016/j.addr.2015.03.012] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 11.4] [Reference Citation Analysis]
204 Platania CB, Di Paola L, Leggio GM, Romano GL, Drago F, Salomone S, Bucolo C. Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach. Front Pharmacol 2015;6:248. [PMID: 26578958 DOI: 10.3389/fphar.2015.00248] [Cited by in Crossref: 43] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
205 Suhasini AN, Wang L, Holder KN, Lin AP, Bhatnagar H, Kim SW, Moritz AW, Aguiar RCT. A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma. Leukemia 2016;30:617-26. [PMID: 26503641 DOI: 10.1038/leu.2015.302] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
206 Molinaro M, Ameri P, Marone G, Petretta M, Abete P, Di Lisa F, De Placido S, Bonaduce D, Tocchetti CG. Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs. Biomed Res Int 2015;2015:138148. [PMID: 26583088 DOI: 10.1155/2015/138148] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
207 Peters EB, Christoforou N, Leong KW, Truskey GA, West JL. Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells. Cell Mol Bioeng 2016;9:38-54. [PMID: 27042236 DOI: 10.1007/s12195-015-0423-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
208 Yang GW, Jiang JS, Lu WQ. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis. Int J Mol Sci 2015;16:24011-31. [PMID: 26473837 DOI: 10.3390/ijms161024011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 62] [Article Influence: 7.9] [Reference Citation Analysis]
209 Tsai CH, Yang MH, Hung AC, Wu SC, Chiu WC, Hou MF, Tyan YC, Wang YM, Yuan SF. Identification of Id1 as a downstream effector for arsenic-promoted angiogenesis via PI3K/Akt, NF-κB and NOS signaling. Toxicol Res (Camb) 2016;5:151-9. [PMID: 30090333 DOI: 10.1039/c5tx00280j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
210 Dautriche CN, Tian Y, Xie Y, Sharfstein ST. A Closer Look at Schlemm's Canal Cell Physiology: Implications for Biomimetics. J Funct Biomater 2015;6:963-85. [PMID: 26402712 DOI: 10.3390/jfb6030963] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
211 Hu Z, Brooks SA, Dormoy V, Hsu CW, Hsu HY, Lin LT, Massfelder T, Rathmell WK, Xia M, Al-Mulla F, Al-Temaimi R, Amedei A, Brown DG, Prudhomme KR, Colacci A, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Lowe L, Jensen L, Bisson WH, Kleinstreuer N. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. Carcinogenesis 2015;36 Suppl 1:S184-202. [PMID: 26106137 DOI: 10.1093/carcin/bgv036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
212 Yang X, Shen F, Hu W, Coleman RL, Sood AK. New ways to successfully target tumor vasculature in ovarian cancer. Curr Opin Obstet Gynecol 2015;27:58-65. [PMID: 25502429 DOI: 10.1097/GCO.0000000000000136] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
213 Van Hove AH, Benoit DS. Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review. Front Bioeng Biotechnol 2015;3:102. [PMID: 26236708 DOI: 10.3389/fbioe.2015.00102] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
214 Hofmann NA, Yang J, Trauger SA, Nakayama H, Huang L, Strunk D, Moses MA, Klagsbrun M, Bischoff J, Graier WF. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis. Br J Pharmacol 2015;172:4107-18. [PMID: 25989290 DOI: 10.1111/bph.13196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
215 Eelen G, de Zeeuw P, Simons M, Carmeliet P. Endothelial cell metabolism in normal and diseased vasculature. Circ Res 2015;116:1231-44. [PMID: 25814684 DOI: 10.1161/CIRCRESAHA.116.302855] [Cited by in Crossref: 286] [Cited by in F6Publishing: 311] [Article Influence: 40.9] [Reference Citation Analysis]
216 Goveia J, Stapor P, Carmeliet P. Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Mol Med. 2014;6:1105-1120. [PMID: 25063693 DOI: 10.15252/emmm.201404156] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 15.4] [Reference Citation Analysis]
217 Zhao Y, Adjei AA. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Oncologist 2015;20:660-73. [PMID: 26001391 DOI: 10.1634/theoncologist.2014-0465] [Cited by in Crossref: 266] [Cited by in F6Publishing: 299] [Article Influence: 38.0] [Reference Citation Analysis]
218 Wang WM, Zhao ZL, Zhang WF, Zhao YF, Zhang L, Sun ZJ. Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma. Mol Med Rep 2015;12:3432-8. [PMID: 25997612 DOI: 10.3892/mmr.2015.3815] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
219 Gevaert T, Moles Lopez X, Sagaert X, Libbrecht L, Roskams T, Rorive S, Decaestecker C, Salmon I, De Ridder D. Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome. PLoS One 2015;10:e0127020. [PMID: 25973881 DOI: 10.1371/journal.pone.0127020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
220 Zhou X, Qi Y. Larynx carcinoma regulates tumor-associated macrophages through PLGF signaling. Sci Rep 2015;5:10071. [PMID: 25961789 DOI: 10.1038/srep10071] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
221 Zhu GC, Yu CY, She L, Tan HL, Li G, Ren SL, Su ZW, Wei M, Huang DH, Tian YQ, Su RN, Liu Y, Zhang X. Metadherin regulation of vascular endothelial growth factor expression is dependent upon the PI3K/Akt pathway in squamous cell carcinoma of the head and neck. Medicine (Baltimore). 2015;94:e502. [PMID: 25674742 DOI: 10.1097/md.0000000000000502] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
222 Deryugina EI, Quigley JP. Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 2015;44-46:94-112. [PMID: 25912949 DOI: 10.1016/j.matbio.2015.04.004] [Cited by in Crossref: 193] [Cited by in F6Publishing: 215] [Article Influence: 27.6] [Reference Citation Analysis]
223 Schoors S, Bruning U, Missiaen R, Queiroz KC, Borgers G, Elia I, Zecchin A, Cantelmo AR, Christen S, Goveia J, Heggermont W, Goddé L, Vinckier S, Van Veldhoven PP, Eelen G, Schoonjans L, Gerhardt H, Dewerchin M, Baes M, De Bock K, Ghesquière B, Lunt SY, Fendt SM, Carmeliet P. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 2015;520:192-7. [PMID: 25830893 DOI: 10.1038/nature14362] [Cited by in Crossref: 312] [Cited by in F6Publishing: 323] [Article Influence: 44.6] [Reference Citation Analysis]
224 Chen Y, Wang X, Liu T, Zhang DS, Wang Y, Gu H, Di W. Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy. Int J Nanomedicine 2015;10:2579-94. [PMID: 25848273 DOI: 10.2147/IJN.S78774] [Cited by in Crossref: 7] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
225 Noy PJ, Lodhia P, Khan K, Zhuang X, Ward DG, Verissimo AR, Bacon A, Bicknell R. Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth. Oncogene 2015;34:5821-31. [PMID: 25745997 DOI: 10.1038/onc.2015.34] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
226 Heindryckx F, Gerwins P. Targeting the tumor stroma in hepatocellular carcinoma. World J Hepatol 2015; 7(2): 165-176 [PMID: 25729472 DOI: 10.4254/wjh.v7.i2.165] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
227 Bag AK, Kim H, Gao Y, Bolding M, Warren PP, Fathallah-Shaykh HM, Gurler D, Markert JM, Fiveash J, Beasley TM, Khawaja A, Friedman GK, Chapman PR, Nabors LB, Han X. Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas. J Neurooncol 2015;122:585-93. [PMID: 25711673 DOI: 10.1007/s11060-015-1751-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
228 Charpentier MS, Tandon P, Trincot CE, Koutleva EK, Conlon FL. A distinct mechanism of vascular lumen formation in Xenopus requires EGFL7. PLoS One 2015;10:e0116086. [PMID: 25705891 DOI: 10.1371/journal.pone.0116086] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
229 Liu Q, Hu T, He L, Huang X, Tian X, Zhang H, He L, Pu W, Zhang L, Sun H, Fang J, Yu Y, Duan S, Hu C, Hui L, Zhang H, Quertermous T, Xu Q, Red-Horse K, Wythe JD, Zhou B. Genetic targeting of sprouting angiogenesis using Apln-CreER. Nat Commun 2015;6:6020. [PMID: 25597280 DOI: 10.1038/ncomms7020] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 10.4] [Reference Citation Analysis]
230 Li H, Wozniak A, Sciot R, Cornillie J, Wellens J, Van Looy T, Vanleeuw U, Stas M, Hompes D, Debiec-Rychter M, Schöffski P. Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models. Transl Oncol 2014;7:665-71. [PMID: 25500074 DOI: 10.1016/j.tranon.2014.09.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
231 Haaga JR, Haaga R, Patel I, Love Z, Moulter J. ALPHA Glycolytic Vasculogenesis Better Correlates With MRI and CT Imaging Techniques Than the Traditional Oxygen Vasculogenesis Theory. American Journal of Roentgenology 2014;203:W724-34. [DOI: 10.2214/ajr.13.11762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
232 Alam MT, Nagao-Kitamoto H, Ohga N, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Taketomi A, Shindoh M, Hida Y, Hida K. Suprabasin as a novel tumor endothelial cell marker. Cancer Sci 2014;105:1533-40. [PMID: 25283635 DOI: 10.1111/cas.12549] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
233 Li H, Takayama K, Wang S, Shiraishi Y, Gotanda K, Harada T, Furuyama K, Iwama E, Ieiri I, Okamoto I, Nakanishi Y. Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression. Cancer Chemother Pharmacol 2014;74:1297-305. [PMID: 25344762 DOI: 10.1007/s00280-014-2610-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
234 Falasca M, Maffucci T. Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts. Front Physiol 2014;5:391. [PMID: 25360116 DOI: 10.3389/fphys.2014.00391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
235 Haubner R, Maschauer S, Einsiedel J, Eder IE, Rangger C, Gmeiner P, Virgolini IJ, Prante O. H-CRRETAWAC-OH, a lead structure for the development of radiotracer targeting integrin α5β1? Biomed Res Int 2014;2014:243185. [PMID: 25374888 DOI: 10.1155/2014/243185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
236 Zhang X, Das SK, Passi SF, Uehara H, Bohner A, Chen M, Tiem M, Archer B, Ambati BK. AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization. Mol Ther 2015;23:226-34. [PMID: 25306972 DOI: 10.1038/mt.2014.199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
237 Rahimi N, Costello CE. Emerging roles of post-translational modifications in signal transduction and angiogenesis. Proteomics 2015;15:300-9. [PMID: 25161153 DOI: 10.1002/pmic.201400183] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
238 Hong H, Chen F, Zhang Y, Cai W. New radiotracers for imaging of vascular targets in angiogenesis-related diseases. Adv Drug Deliv Rev 2014;76:2-20. [PMID: 25086372 DOI: 10.1016/j.addr.2014.07.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
239 Verdegem D, Moens S, Stapor P, Carmeliet P. Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab 2014;2:19. [PMID: 25250177 DOI: 10.1186/2049-3002-2-19] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 8.9] [Reference Citation Analysis]
240 Norton KA, Han Z, Popel AS, Pandey NB. Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells. Onco Targets Ther 2014;7:1571-82. [PMID: 25228815 DOI: 10.2147/OTT.S65055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
241 Noort AR, van Zoest KP, Weijers EM, Koolwijk P, Maracle CX, Novack DV, Siemerink MJ, Schlingemann RO, Tak PP, Tas SW. NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. J Pathol 2014;234:375-85. [PMID: 25043127 DOI: 10.1002/path.4403] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 7.4] [Reference Citation Analysis]
242 Su ZL, Gao F, Lv ZC, Zhang X. SiRNA-mediated silencing of VEGFR-3 reduces proliferation, adhesion and migration of colorectal cancer cells. Shijie Huaren Xiaohua Zazhi 2014; 22(24): 3573-3579 [DOI: 10.11569/wcjd.v22.i24.3573] [Reference Citation Analysis]
243 Gallach S, Calabuig-Fariñas S, Jantus-Lewintre E, Camps C. MicroRNAs: promising new antiangiogenic targets in cancer. Biomed Res Int 2014;2014:878450. [PMID: 25197665 DOI: 10.1155/2014/878450] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
244 Feng H, Lopez GY, Kim CK, Alvarez A, Duncan CG, Nishikawa R, Nagane M, Su AJ, Auron PE, Hedberg ML, Wang L, Raizer JJ, Kessler JA, Parsa AT, Gao WQ, Kim SH, Minata M, Nakano I, Grandis JR, McLendon RE, Bigner DD, Lin HK, Furnari FB, Cavenee WK, Hu B, Yan H, Cheng SY. EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. J Clin Invest 2014;124:3741-56. [PMID: 25061874 DOI: 10.1172/JCI73093] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
245 Haubner R, Maschauer S, Prante O. PET radiopharmaceuticals for imaging integrin expression: tracers in clinical studies and recent developments. Biomed Res Int 2014;2014:871609. [PMID: 25013808 DOI: 10.1155/2014/871609] [Cited by in Crossref: 31] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
246 Raimondi C, Fantin A, Lampropoulou A, Denti L, Chikh A, Ruhrberg C. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells. J Exp Med 2014;211:1167-83. [PMID: 24863063 DOI: 10.1084/jem.20132330] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 10.9] [Reference Citation Analysis]
247 Allen AB, Gazit Z, Su S, Stevens HY, Guldberg RE. In vivo bioluminescent tracking of mesenchymal stem cells within large hydrogel constructs. Tissue Eng Part C Methods 2014;20:806-16. [PMID: 24576050 DOI: 10.1089/ten.TEC.2013.0587] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
248 D'Amico G, Korhonen EA, Anisimov A, Zarkada G, Holopainen T, Hägerling R, Kiefer F, Eklund L, Sormunen R, Elamaa H, Brekken RA, Adams RH, Koh GY, Saharinen P, Alitalo K. Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy. J Clin Invest 2014;124:824-34. [PMID: 24430181 DOI: 10.1172/JCI68897] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
249 Aguilera KY, Rivera LB, Hur H, Carbon JG, Toombs JE, Goldstein CD, Dellinger MT, Castrillon DH, Brekken RA. Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. Cancer Res 2014;74:1032-44. [PMID: 24346431 DOI: 10.1158/0008-5472.CAN-13-2800] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
250 Lameire N. Nephrotoxicity of recent anti-cancer agents. Clin Kidney J 2014;7:11-22. [PMID: 25859345 DOI: 10.1093/ckj/sft135] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]